Wikipedia:Articles for deletion/Novelos Therapeutics
- Novelos Therapeutics (edit | talk | history | protect | delete | links | watch | logs | views) – (View log · AfD statistics)
- (Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)
Declined speedy (I have no idea why, many companies have rights to pharma compounds, but that doesn't make them "important or significant"). Most of the Ghits I come up with are directory-type listings or regurgitation of company press releases, not amounting to the significant coverage required by WP:N and WP:CORP. NB article was created by editor with WP:COI, now blocked for spamming. ukexpat (talk) 21:41, 3 December 2009 (UTC)
- Delete per nom. No evidence of notability. WP:SOAP 7 22:52, 3 December 2009 (UTC)
- Delete - I understood declining the speedy, A7 isn't about an article being notable, but asserting that it's notable. The article does so, if weakly. But it certainly falls short of actually being notable; I made a real effort to find sources, but I can't find anything but press releases. I suppose that it's worth mentioning that the article is part of a coordinated effort to promote this company on the web, per WP:COIN#Novelos. -- Atama頭 23:03, 3 December 2009 (UTC)
- Delete - I can find only press releases. -- Whpq (talk) 11:10, 4 December 2009 (UTC)
- Delete Appears to be a lot of Google hits (some of which are promotional attempts) but no evidence of notability per WP:CORP. Johnuniq (talk) 01:42, 5 December 2009 (UTC)
- Delete per WP:CRYSTAL - their drugs are still in trials. Bearian (talk) 17:01, 5 December 2009 (UTC)
- Delete: I can't find significant coverage for this company. Joe Chill (talk) 17:09, 6 December 2009 (UTC)
- Do not Delete according to the National Cancer Institute:
NOV-002 is manufactured by Novelos Therapeutics A stabilized formulation of disodium glutathione disulfide (GSSG; oxidized glutathione) and cisplatin (1000:1) with potential chemoprotective and immunomodulating activities. Mimicking endogenous GSSG, glutathione disulfide NOV-002 acts as a competitive substrate for gamma-glutamyl-transpeptidase (GGT), which may result in the S-glutathionylation of proteins, predominantly actin, a redox stress on endoplasmic reticulum (ER), and ER stress-induced apoptosis; S-glutathionylation may be stimulated by reactive oxygen species (ROS) liberated by a glutathione disulfide NOV-002-induced increase in GGT activity. Glutathione disulfide NOV-002 may also induce phosphorylation of proteins such as ERK and p38, two kinases that play critical regulatory roles in cell proliferation and apoptosis. The cisplatin component of this agent does not provide an effective therapeutic concentration of cisplatin in vivo. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus) Synonym: oxidized glutathione NOV-002 Foreign brand name: Glutoxim Code name: NOV-002 source: http://www.cancer.gov/drugdictionary/?CdrID=494994 —Preceding unsigned comment added by 4.238.245.42 (talk) 03:48, 9 December 2009 (UTC)
- Er...so? Plenty of companies make products but that doesn't mean they fulfill Wikipedia's notability requirements. – ukexpat (talk) 03:56, 9 December 2009 (UTC)
- Do not Delete
Dr John Bell et al, To be eligible in meeting wikipedia standards in addition to being part of the National Cancer Institute reference. NOV-002 manufactured by Novelos is making the Media and that substantiates a second criteria for Wikipedia listing:
Vernay Mills of Miami Florida her breast cancer was cured made the Channel 7 FOX news story on Television.
Medical Reports: Targets Tumors http://www.wsvn.com/features/articles/medicalreports/MI137669/